1. Why Can’t Surgeons Treat Older Patients the Same as Younger Patients?

   • Riccardo A. Audisio
   • Charles M. Balch

   Pancreatic Tumors 25 July 2016 Pages: 4123 - 4125

   

2. What is the OPTiMal Way to Manage In-Transit Disease?

   • Kelly Olino
   • Douglas S. Tyler

   Melanomas 05 July 2016 Pages: 4126 - 4129

3. Adjuvant Chemotherapy: What’s the Rush?

   • Clifford S. Cho

   Gastrointestinal Oncology 28 July 2016 Pages: 4130 - 4133

4. Active Surveillance for DCIS: The Importance of Selection Criteria and Monitoring

   • Lars J. Grimm
   • E. Shelley Hwang

   Breast Oncology 04 October 2016 Pages: 4134 - 4136

5. Comparison of 1800 Robotic and Open Partial Nephrectomies for Renal Tumors

   • Adam Bezinque
   • Brian R. Lane

   Urologic Oncology 11 July 2016 Pages: 4137 - 4138

6. Comparison of Comorbid Medical Conditions in the National Cancer Database and the SEER–Medicare Database

   • Chun Chieh Lin
   • Katherine S. Virgo
   • Elizabeth M. Ward

   Healthcare Policy and Outcomes 17 August 2016 Pages: 4139 - 4148

   

7. Deviations from Expected Treatment of Pancreatic Cancer in Octogenarians: Analysis of Patient and Surgeon Factors

   • Jonathan C. King
   • Mazen Zenati
   • Melissa E. Hogg

   Pancreatic Tumors 26 July 2016 Pages: 4149 - 4155

   

8. Early Recurrence and Omission of Adjuvant Therapy after Pancreaticoduodenectomy Argue against a Surgery-First Approach

   • Brent T. Xia
   • David A. Habib
   • Daniel E. Abbott

   Pancreatic Tumors 26 July 2016 Pages: 4156 - 4164

   

9. Evolving Trends Towards Minimally Invasive Surgery for Solid-Pseudopapillary Neoplasms

   • Camille L. Stewart
   • Cheryl Meguid
   • Barish H. Edil

   Pancreatic Tumors 10 August 2016 Pages: 4165 - 4168

10. Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial

    • Robert H. I. Andtbacka
    • Merrick Ross
    • Howard L. Kaufman

    Melanomas Open access 24 June 2016 Pages: 4169 - 4177

    

11. Sentinel Lymph Node Biopsy in Thin Cutaneous Melanoma: A Systematic Review and Meta-Analysis

    • Erin Cordeiro
    • Mai-Kim Gervais
    • Frances C. Wright

    Melanomas 01 March 2016 Pages: 4178 - 4188

    

12. Melanoma in Mexico: Clinicopathologic Features in a Population with Predominance of Acral Lentiginous Subtype

    • Leonardo S. Lino-Silva
    • Jorge A. Domínguez-Rodríguez
    • Mario Cuellar-Hubbe

    Melanomas 11 July 2016 Pages: 4189 - 4194

    

13. Clinical Prognostic Markers in Stage IIIB Melanoma

    • Max F. Madu
    • Michel W. J. M. Wouters
    • Alexander C. J. van Akkooi

    Melanomas 05 July 2016 Pages: 4195 - 4202

    

14. Timing of Adjuvant Chemotherapy and Impact on Survival for Resected Gastric Cancer

    • Erin K. Greenleaf
    • Afif N. Kulaylat
    • Joyce Wong

    Gastrointestinal Oncology 26 July 2016 Pages: 4203 - 4213

    

15. Development of a Prognostic Nomogram for Patients with Peritoneally Metastasized Colorectal Cancer Treated with Cytoreductive Surgery and HIPEC

    • Geert A. Simkens
    • Thijs R. van Oudheusden
    • Ignace H. de Hingh

    Gastrointestinal Oncology 30 March 2016 Pages: 4214 - 4221

    

16. Pseudomyxoma Peritonei of Extra-Appendiceal Origin: A Comparative Study

    • Dario Baratti
    • Shigeki Kusamura
    • Marcello Deraco

    Gastrointestinal Oncology 28 June 2016 Pages: 4222 - 4230

    

17. Adverse Events Postoperatively Had No Impact on Long-Term Survival of Patients Treated with Cytoreductive Surgery with Heated Intraperitoneal Chemotherapy for Appendiceal Cancer with Peritoneal Metastases

    • Chukwuemeka Ihemelandu
    • Michael N. Mavros
    • Paul Sugarbaker

    Gastrointestinal Oncology 23 June 2016 Pages: 4231 - 4237

    

18. Increased RhoA Activity Predicts Worse Overall Survival in Patients Undergoing Surgical Resection for Lauren Diffuse-Type Gastric Adenocarcinoma

    • Kevin K. Chang
    • Soo-Jeong Cho
    • Sam S. Yoon

    Gastrointestinal Oncology 30 June 2016 Pages: 4238 - 4246

    

19. Pylorus-Preserving Surgery Based on the Sentinel Node Concept in Early Gastric Cancer

    • Ayako Shimada
    • Hiroya Takeuchi
    • Yuko Kitagawa

    Gastrointestinal Oncology 30 June 2016 Pages: 4247 - 4252

    

20. Women with Low-Risk DCIS Eligible for the LORIS Trial After Complete Surgical Excision: How Low Is Their Risk After Standard Therapy?

    • Melissa Pilewskie
    • Cristina Olcese
    • Kimberly J. Van Zee

    Breast Oncology 20 October 2016 Pages: 4253 - 4261

    

21. Preoperative Paravertebral Block Improves Postoperative Pain Control and Reduces Hospital Length of Stay in Patients Undergoing Autologous Breast Reconstruction after Mastectomy for Breast Cancer

    • Rajiv P. Parikh
    • Ketan Sharma
    • Terence M. Myckatyn

    Breast Oncology 03 August 2016 Pages: 4262 - 4269

    

22. Close and Positive Lumpectomy Margins are Associated with Similar Rates of Residual Disease with Additional Surgery

    • Simon Fitzgerald
    • Anya Romanoff
    • Elisa R. Port

    Breast Oncology 31 August 2016 Pages: 4270 - 4276

    

23. Comparison of 1800 Robotic and Open Partial Nephrectomies for Renal Tumors

    • Benoit Peyronnet
    • Thomas Seisen
    • French Comittee of Urologic Oncology (CCAFU)

    Urologic Oncology 13 July 2016 Pages: 4277 - 4283

    

24. Could Magnetic Resonance Imaging Help to Identify the Presence of Prostate Cancer Before Initial Biopsy? The Development of Nomogram Predicting the Outcomes of Prostate Biopsy in the Chinese Population

    • Dong Fang
    • Chenglin Zhao
    • Liqun Zhou

    Urologic Oncology 27 July 2016 Pages: 4284 - 4292

    

25. The Disproportionate Effect of Perioperative Complications on Mortality within 1 Year After Colorectal Cancer Resection in Octogenarians

    • Leonardo C. Duraes
    • Luca Stocchi
    • Feza H. Remzi

    Colorectal Cancer 26 July 2016 Pages: 4293 - 4301

26. Long-Term Outcome of Rectal Cancer With Clinically (EUS/MRI) Metastatic Mesorectal Lymph Nodes Treated by Neoadjuvant Chemoradiation: Role of Organ Preservation Strategies in Relation to Pathologic Response

    • Claudio Belluco
    • Marco Forlin
    • Antonino De Paoli

    Colorectal Cancer Open access 03 August 2016 Pages: 4302 - 4309

    

27. Incidence, Risk Factors, and Clinical Outcomes of Incidental Parathyroidectomy During Thyroid Surgery

    • Megan K. Applewhite
    • Michael G. White
    • Raymon H. Grogan

    Endocrine Tumors 19 August 2016 Pages: 4310 - 4315

    

28. Advanced Pseudomyxoma Peritonei Requiring Gastrectomy to Achieve Complete Cytoreduction Results in Good Long-Term Oncologic Outcomes

    • Francesco Di Fabio
    • Akash Mehta
    • Brendan Moran

    Gastrointestinal Oncology 05 July 2016 Pages: 4316 - 4321

    

29. Staging for Remnant Gastric Cancer: The Metastatic Lymph Node Ratio vs. the UICC 7th Edition System

    • Masatoshi Nakagawa
    • Yoon Young Choi
    • Sung Hoon Noh

    Gastrointestinal Oncology 01 July 2016 Pages: 4322 - 4331

    

30. Yield of Staging Laparoscopy and Lavage Cytology for Radiologically Occult Peritoneal Carcinomatosis of Gastric Cancer

    • Naruhiko Ikoma
    • Mariela Blum
    • Brian D. Badgwell

    Gastrointestinal Oncology 06 July 2016 Pages: 4332 - 4337

    

31. Curative Surgical Resection as a Component of Multimodality Therapy for Peritoneal Metastases from Goblet Cell Carcinoids

    • Michal Radomski
    • Reetesh K. Pai
    • Haroon A. Choudry

    Gastrointestinal Oncology 11 July 2016 Pages: 4338 - 4343

    

32. Sex Disparity in Gastric Cancer: Female Sex is a Poor Prognostic Factor for Advanced Gastric Cancer

    • Hae Won Kim
    • Jie-Hyun Kim
    • Seung Ho Choi

    Gastrointestinal Oncology 28 July 2016 Pages: 4344 - 4351

    

33. Systematic Review of Resection Rates and Clinical Outcomes After FOLFIRINOX-Based Treatment in Patients with Locally Advanced Pancreatic Cancer

    • Steffi J. Rombouts
    • Marieke S. Walma
    • Marc G. Besselink

    Gastrointestinal Oncology Open access 01 July 2016 Pages: 4352 - 4360

    

34. Impact of Radical Hysterectomy on Survival in Patients with Stage 2 Type1 Endometrial Carcinoma: A Matched Cohort Study

    • Juliette Phelippeau
    • Martin Koskas

    Gynecologic Oncology 05 July 2016 Pages: 4361 - 4367

    

35. Low-Grade Salivary Gland Cancers: Treatment Outcomes, Extent of Surgery and Indications for Postoperative Adjuvant Radiation Therapy

    • Jae-Keun Cho
    • Byung-Woo Lim
    • Han-Sin Jeong

    Head and Neck Oncology 24 June 2016 Pages: 4368 - 4375

    

36. Risk Factors and Survival Associated with Distant Metastasis in Patients with Carcinoma of the Salivary Gland

    • Soo Jung Nam
    • Jong-Lyel Roh
    • Sang Yoon Kim

    Head and Neck Oncology 23 June 2016 Pages: 4376 - 4383

    

37. Fractal Dimension of Tc-99m DTPA GSA Estimates Pathologic Liver Injury due to Chemotherapy in Liver Cancer Patients

    • Yukihiko Hiroshima
    • Kiyohiko Shuto
    • Kuniya Tanaka

    Hepatobiliary Tumors 20 July 2016 Pages: 4384 - 4391

    

38. Outcomes for Patients with Recurrent Intrahepatic Cholangiocarcinoma After Surgery

    • Hyeong Min Park
    • Sung Pil Yun
    • Sang-Jae Park

    Hepatobiliary Tumors 31 August 2016 Pages: 4392 - 4400

    

39. Changing Odds of Survival Over Time among Patients Undergoing Surgical Resection of Gallbladder Carcinoma

    • Stefan Buettner
    • Georgios Antonios Margonis
    • Timothy M. Pawlik

    Hepatobiliary Tumors 05 August 2016 Pages: 4401 - 4409

    

40. Predictors of Treatment Decisions in Multidisciplinary Oncology Meetings: A Quantitative Observational Study

    • Tayana Soukup
    • Benjamin W. Lamb
    • Nick Sevdalis

    Medical Oncology 05 July 2016 Pages: 4410 - 4417

    

41. The Trans-Atlantic Retroperitoneal Sarcoma Working Group (TARPSWG): “Red wine or white”?

    • William W. Tseng
    • Raphael E. Pollock
    • Alessandro Gronchi

    Bone and Soft Tissue Sarcomas 09 September 2016 Pages: 4418 - 4420

    

42. A Choice of Wine

    • Barry Feig
    • Robert Benjamin

    Bone and Soft Tissue Sarcomas 06 October 2016 Pages: 4421 - 4422